US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist

49.120
+1.370+2.87%

Close Feb 28 16:00 ET

49.120
0.0000.00%

Post 16:16 ET

3.91BMarket Cap-13.10P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akero Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 0.000	--
--	2025/Q1	-- / 0.000	--
--	2024/Q4	0.000 / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 0.000--

--2025/Q1-- / 0.000--

--2024/Q40.000 / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Akero Therapeutics Earnings Reports

Akero Therapeutics | 8-K: Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 28 08:31 ET

Akero Therapeutics | 10-K: FY2024 Annual Report

Feb 28 07:31 ET

Akero Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 07:35 ET

Akero Therapeutics | 8-K: Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 8, 2024 07:25 ET